All In Biotech

Drugs by condition

Drugs approved for idiopathic pulmonary fibrosis

Brand-name prescription drugs and biologics whose FDA label lists idiopathic pulmonary fibrosis as an approved use. Matched on the label phrases: "idiopathic pulmonary fibrosis".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

8

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

2

New molecular entities and new biologics

In development

37

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for idiopathic pulmonary fibrosis.

  • Jascayd (Nerandomilast) · Boehringer Ingelheim NovelBreakthrough therapyPriority reviewOrphanOct 7, 2025
  • Yutrepia (Treprostinil Sodium) · Liquidia Tech May 23, 2025
  • Tyvaso Dpi (Treprostinil) · United Therap Priority reviewOrphanMay 23, 2022
  • Esbriet (Pirfenidone) · Legacy OrphanJan 11, 2017
  • Ofev (Nintedanib Esylate) · Boehringer Ingelheim NovelBreakthrough therapyPriority reviewOrphanOct 15, 2014

All approved drugs for idiopathic pulmonary fibrosis, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 35 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Prostacycline Vasodilator (2)

  • Tyvaso Dpi Treprostinil · United Therap · 2022
  • Tyvaso Treprostinil · United Therap · 2009

Pyridone (1)

  • Esbriet Pirfenidone · Legacy · 2017

Class not listed in FDA's data (5)

  • Jascayd Nerandomilast · Boehringer Ingelheim · 2025
  • Ofev Nintedanib Esylate · Boehringer Ingelheim · 2014
  • Yutrepia Treprostinil Sodium · Liquidia Tech · 2025
  • Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
  • Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986

Drugs in development for idiopathic pulmonary fibrosis

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • HSK44459Phase 39 trials

    Haisco Pharmaceutical Group Co., Ltd. · Psoriasis, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis

  • Inhaled TreprostinilLIQ861 Inhaled Treprostinil, Inhaled prostacyclinPhase 35 trials

    United Therapeutics · Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

  • BMS-986278AdmilparantPhase 33 trials

    Bristol Myers Squibb · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis

  • HEC585Phase 33 trials

    Sunshine Lake Pharma Co., Ltd. · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF), Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)

  • BI 1015550Phase 32 trials

    Boehringer Ingelheim · Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis

  • DeupirfenidonePhase 32 trials

    PureTech · Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis

  • INS018_055Phase 32 trials

    InSilico Medicine Hong Kong Limited · Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis

  • REGEND001Phase 32 trials

    Regend Therapeutics · COPD (Chronic Obstructive Pulmonary Disease), Idiopathic Pulmonary Fibrosis

  • TDI01Phase 32 trials

    Beijing Tide Pharmaceutical Co., Ltd · GVHD, Chronic, Idiopathic Pulmonary Fibrosis (IPF)

  • AK3280Phase 31 trial

    Shanghai Ark Biopharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)

  • SC1011Phase 31 trial

    Guangzhou JOYO Pharma Co., Ltd · Idiopathic Pulmonary Fibrosis

  • HB0056Phase 22 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Asthma, Idiopathic Pulmonary Fibrosis (IPF)

  • IfetrobanPhase 22 trials

    Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited

  • TTI-101Phase 22 trials

    Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis

  • ABBV-142Phase 21 trial

    AbbVie · Idiopathic Pulmonary Fibrosis

  • AGMB-447Phase 21 trial

    Agomab Spain S.L.U. · Idiopathic Pulmonary Fibrosis (IPF)

  • AP02Phase 21 trial

    Avalyn Pharma Inc. · Idiopathic Pulmonary Fibrosis (IPF)

  • AZD8965Phase 21 trial

    AstraZeneca · Idiopathic Pulmonary Fibrosis (IPF)

  • BBT-877Phase 21 trial

    Bridge Biotherapeutics, Inc. · Idiopathic Pulmonary Fibrosis

  • BC006Phase 21 trial

    Dragonboat Biopharmaceutical Company Limited · Idiopathic Pulmonary Fibrosis (IPF)

More on idiopathic pulmonary fibrosis: recruiting trials · published research

Related in respiratory: Pulmonary arterial hypertension · Asthma · COPD · Cystic fibrosis · Allergies (allergic rhinitis)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.